Veterinary Medicine Information website

CLAVASEPTIN P 250 MG TABLETS FOR DOGS

Authorised
  • Amoxicillin trihydrate
  • Potassium clavulanate

Product identification

Medicine name:
CLAVASEPTIN P 250 MG TABLETS FOR DOGS
Active substance:
  • Amoxicillin trihydrate
  • Potassium clavulanate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    229.56
    milligram(s)
    /
    1.00
    Tablet
  • Potassium clavulanate
    59.55
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetoquinol Especialidades Veterinarias S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 1663 ESP
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0407/002
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 13/12/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 13/12/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 13/12/2024